Metastatic HCC
Showing 1 - 25 of >10,000
Locally Advanced Hepatocellular Carcinoma, Recurrent Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial (RP3,
Not yet recruiting
- Locally Advanced Hepatocellular Carcinoma
- +2 more
- RP3
- +2 more
- (no location specified)
Feb 8, 2023
Hepatocellular Carcinoma Non-resectable, Metastatic Colorectal Cancer, Liver Cancer Trial in Grafton (Eye90 Microspheres)
Recruiting
- Hepatocellular Carcinoma Non-resectable
- +2 more
- Eye90 Microspheres
-
Grafton, New ZealandAuckland District Health Board
Jan 30, 2023
Hepatocellular Carcinoma, Liver Cancer, Adult, Liver Tumor Trial in Duarte (ECT204 T cells)
Recruiting
- Hepatocellular Carcinoma
- +3 more
- ECT204 T cells
-
Duarte, California
- +1 more
Jan 9, 2023
Hepatocellular Carcinoma Trial (Livmoniplimab, Budigalimab, Durvalumab)
Not yet recruiting
- Hepatocellular Carcinoma
- Livmoniplimab
- +5 more
- (no location specified)
Oct 26, 2023
Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Hepatocellular Carcinoma Trial run by the NCI (Cyclophosphamide,
Recruiting
- Hepatocellular Carcinoma
- +2 more
- Cyclophosphamide
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Advanced Hepatocellular Carcinoma (HCC), Gastric Cancer Metastatic to Liver, Colorectal Cancer Metastatic to Liver Trial in
Recruiting
- Advanced Hepatocellular Carcinoma (HCC)
- +2 more
-
Duarte, California
- +2 more
Aug 29, 2022
Hepatocellular Carcinoma, Renal Cell Carcinoma Trial in Australia, New Zealand (APL-501, APL-101, Nivolumab)
Terminated
- Hepatocellular Carcinoma
- Renal Cell Carcinoma
- APL-501
- +2 more
-
Albury, New South Wales, Australia
- +8 more
May 3, 2022
Hepatoblastoma, Hepatocellular Carcinoma (HCC), Liver Tumors Trial in Boston (ET140203 T Cells)
Recruiting
- Hepatoblastoma
- +5 more
- ET140203 T Cells
-
Boston, MassachusettsDana-Farber/Boston Children's Cancer and Blood Disorders Center
Aug 12, 2022
Carcinoma, Hepatocellular, Gastric/Gastroesophageal Junction Cancer Trial in China (Sitravatinib, Sitravatinib plus
Active, not recruiting
- Carcinoma, Hepatocellular
- Gastric/Gastroesophageal Junction Cancer
- Sitravatinib
- +2 more
-
Hefei, Anhui, China
- +17 more
Jul 28, 2022
HCC - Hepatocellular Carcinoma, Metastatic Cancer, Metastatic Tumor Trial in France (Ipilimumab Injection, Atezolizumab
Not yet recruiting
- HCC - Hepatocellular Carcinoma
- +2 more
- Ipilimumab Injection
- +2 more
-
Créteil, France
- +7 more
Dec 27, 2022
Unresectable, Non-metastatic Hepatocellular Carcinoma Trial in China (biological, drug, procedure)
Recruiting
- Unresectable, Non-metastatic Hepatocellular Carcinoma
- AK104
- +2 more
-
Beijing, Beijing, China
- +4 more
Aug 11, 2022
Hepatocellular Cancer, Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial run by the NCI (durvalumab,
Recruiting
- Hepatocellular Cancer
- +2 more
- durvalumab
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Metastatic Hepatocellular Carcinoma, HCC, Combinations of Drugs; Dependence Trial in Tainan, Taipei (GT90001 and Nivolumab)
Active, not recruiting
- Metastatic Hepatocellular Carcinoma
- +2 more
- GT90001 and Nivolumab
-
Tainan, Taiwan
- +2 more
Jul 8, 2021
Hepatocellular Carcinoma Trial in Shanghai (Multifocal Stereotactic Radiotherapy, Atezolizumab Injection [Tecentriq],
Recruiting
- Hepatocellular Carcinoma
- Multifocal Stereotactic Radiotherapy
- +2 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
May 27, 2022
Locally Advanced or Metastatic Solid Tumors, NSCLC, HNSCC Trial in Australia, United States (RO7502175, Atezolizumab)
Recruiting
- Locally Advanced or Metastatic Solid Tumors
- +10 more
-
Aurora, Colorado
- +6 more
Jan 4, 2023
Liver Tumor, HCC, Metastasis Trial in Worldwide (HistoSonics Histotripsy)
Recruiting
- Liver Tumor
- +2 more
- HistoSonics Histotripsy
-
Braunschweig, Germany
- +5 more
Oct 13, 2022
Liver Tumor, HCC, Metastasis Trial in United States (HistoSonics Histotripsy)
Recruiting
- Liver Tumor
- +2 more
- HistoSonics Histotripsy
-
Miami, Florida
- +7 more
Jan 3, 2023
Hepatocellular Carcinoma, Liver Cancer, Liver Tumor Trial in United States (ET140203 autologous T cell product)
Recruiting
- Hepatocellular Carcinoma
- +3 more
- ET140203 autologous T cell product
-
Duarte, California
- +3 more
Jul 1, 2022
Stage IV HCC, Immunotherapy, SBRT Trial in Chengdu (Stereotactic body radiation therapy, Anti-PD-1 antibody drug named
Recruiting
- Stage IV HCC
- +2 more
- Stereotactic body radiation therapy
- Anti-PD-1 antibody drug named Sintilimab
-
Chengdu, Sichuan, ChinaWest China Hospital
Sep 6, 2020
BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in
Not yet recruiting
- BCLC Stage B Hepatocellular Carcinoma
- +10 more
- Ipilimumab
- Nivolumab
-
Miami, Florida
- +4 more
Aug 23, 2022
Solid Tumor, Cancer, Carcinoma Trial in United States (Mogamulizumab + Nivolumab)
Completed
- Solid Tumor
- +4 more
- Mogamulizumab + Nivolumab
-
Gilbert, Arizona
- +14 more
Jul 27, 2022
Optimizing Y90 Therapy for Radiation Lobectomy
Recruiting
- HCC
- +4 more
- Y90 radioembolization
-
Chicago, IllinoisNorthwestern University
Aug 27, 2021
Clear Cell Renal Cell Carcinoma Trial in United States (Batiraxcept, Cabozantinib (Cabo), Nivolumab)
Active, not recruiting
- Clear Cell Renal Cell Carcinoma
- Batiraxcept
- +2 more
-
Baltimore, Maryland
- +16 more
Jan 17, 2023
Recurrent Hepatocellular Carcinoma, Refractory Liver Carcinoma, Stage IV Hepatocellular Carcinoma AJCC v8 Trial in Scottsdale,
Active, not recruiting
- Recurrent Hepatocellular Carcinoma
- +4 more
- Cyclophosphamide
- +2 more
-
Scottsdale, Arizona
- +2 more
Oct 7, 2022
Hepatocellular Carcinoma Trial in Worldwide (Budigalimab, Livmoniplimab, Lenvatinib)
Not yet recruiting
- Hepatocellular Carcinoma
- Budigalimab
- +3 more
-
Prescott Valley, Arizona
- +58 more
Apr 10, 2023